BRISBANE, Calif., May 21, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today announced that it has entered into a definitive agreement to acquire ImmuMetrix, Inc., a privately held Palo Alto, California based development-stage transplant diagnostics company founded by Stephen Quake, D.Phil., with R&D programs and intellectual property in cell-free DNA.
Help employers find you! Check out all the jobs and post your resume.
